Skip to main content
Top
Published in: Journal of Cancer Education 3/2020

01-06-2020 | Care

Recognizing the Need for Oncology Education in Canadian Baccalaureate Nursing Programs

Author: Cindy Davidson

Published in: Journal of Cancer Education | Issue 3/2020

Login to get access

Abstract

There is a critical need for quality oncology education in Canadian baccalaureate nursing programs considering the vast amount of cancer diagnoses and deaths in the Canadian population, as well as the likelihood that all nurses will care for oncology patients in various settings. The incidence and mortality of cancer within the Canadian population impact the need to incorporate an all-inclusive view of cancer care into baccalaureate nursing curriculums and develop nurse leaders in oncology at this level. Currently, Canadian nursing programs are generalist programs and provide little oncology content especially in the clinical setting. It is essential that baccalaureate nursing programs examine strategies to incorporate a comprehensive view of cancer care into programs to ensure that baccalaureate nursing students meet the entry to practice competencies to care for patients across the cancer care trajectory.
Literature
9.
go back to reference Lippe M, Volker D, Jones T, Carter P (2017) Evaluating end-of-life care education within nursing programs: a method for targeted curriculum evaluation. J Hosp Palliat Nurs 19(3):266–274CrossRef Lippe M, Volker D, Jones T, Carter P (2017) Evaluating end-of-life care education within nursing programs: a method for targeted curriculum evaluation. J Hosp Palliat Nurs 19(3):266–274CrossRef
Metadata
Title
Recognizing the Need for Oncology Education in Canadian Baccalaureate Nursing Programs
Author
Cindy Davidson
Publication date
01-06-2020
Publisher
Springer US
Keyword
Care
Published in
Journal of Cancer Education / Issue 3/2020
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01620-4

Other articles of this Issue 3/2020

Journal of Cancer Education 3/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine